国际皮肤镜学会关于恶性雀斑样痣管理的共识建议
国际皮肤镜学会组织53名多学科专家,通过结构化共识方法制定恶性雀斑样痣的诊断、治疗和随访建议。共识强调皮肤镜和反射式共聚焦显微镜等无创成像辅助诊断与边界界定,完整手术切除为首选治疗,手术不宜时可选择局部咪喹莫特或放疗,应避免盲目的破坏性治疗,并需密切临床与影像随访。
要点
- 皮肤镜和反射式共聚焦显微镜辅助恶性雀斑样痣的诊断、活检定位和边界界定。
- 完整手术切除是恶性雀斑样痣的首选治疗,标准手术无法推荐明确安全切缘。
- 手术不宜时局部咪喹莫特或放疗为有效替代,应避免盲目的破坏性方法。
核心结论
- 完整手术切除仍是恶性雀斑样痣的首选治疗,标准手术无法推荐明确安全切缘。
- 手术不宜时局部咪喹莫特或放疗为有效替代方案。
- 应避免盲目的破坏性方法,并需密切临床与影像随访。
研究设计与样本
- 国际皮肤镜学会协调53名多学科专家组成全球 consortium,通过结构化共识制定建议。
- 共识基于对当前科学证据和临床实践标准的全面回顾。
主要发现
- 恶性雀斑样痣诊断和管理因进展缓慢、常位于美容敏感部位及亚临床周边扩展而具有挑战性。
- 无创皮肤成像技术(尤其皮肤镜和反射式共聚焦显微镜)有助于诊断、活检定位、病灶 delineation 和治疗后监测。
- 多次部分活检有助于确认诊断并排除浸润。
- 局部咪喹莫特可作为主要、辅助或新辅助治疗。
关键数值与推荐
- 完整手术切除是首选治疗,但标准手术无法推荐明确安全切缘。
- 对于大或边界不清的病灶,优先选择边缘控制技术。
- 手术不宜时,局部咪喹莫特和放疗是有效替代方案。
- 应避免盲目的破坏性方法。
- 需要密切的临床和影像随访。
临床怎么用
- 对恶性雀斑样痣应使用皮肤镜和反射式共聚焦显微镜辅助诊断和边界界定。
- 多次部分活检用于确认诊断和排除浸润。
- 手术不宜时可选择局部咪喹莫特或放疗,但不应采用盲目的破坏性治疗。
局限性
- 恶性雀斑样痣的自然病史尚不完全清楚,针对该特定实体的循证管理策略有限。
- 高质量证据稀缺,共识建议基于专家共识和现有证据。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Lentigo maligna (LM) is a subtype of cutaneous melanoma in situ that develops on chronically sun-damaged skin in elderly individuals. Its diagnosis and management remain challenging due to its slow progression, frequent occurrence on cosmetically sensitive areas in frail individuals, and tendency for subclinical peripheral extension. Despite its potential for invasive transformation, the natural history of LM remains incompletely understood and evidence-based management strategies for this specific entity remain limited. This work aims to bridge the gap between scarce high-quality evidence and the clinicians' need for practical guidance on LM management by formulating evidence-based and expert consensus-driven recommendations for diagnosis, treatment and follow-up. Under the coordination of the International Dermoscopy Society, a global, multidisciplinary consortium of 53 experts-including dermatologists, dermato-oncologists, dermatologic surgeons, radiologists, radiotherapists, pathologists and epidemiologists-formulated recommendations through structured consensus, informed by a comprehensive review of current scientific evidence and clinical practice standards. Optimal management of LM requires accurate diagnosis and individualized treatment planning. Non-invasive skin imaging techniques, especially dermoscopy and reflectance confocal microscopy, aid in diagnosis, biopsy orientation, lesion delineation and post-treatment monitoring. Multiple partial biopsies help confirm diagnosis and rule out invasion. Complete surgical excision remains the first treatment option. No definitive safety margins can be recommended for standard surgery; margin-controlled techniques are preferable for large or ill-defined lesions. Topical imiquimod and radiotherapy are effective alternatives where surgery is unsuitable. Topical imiquimod is useful as primary, adjuvant or neoadjuvant therapy. Blind destructive methods should be avoided. Close clinical and imaging follow-up is needed. Patient-centred care, shared decision-making, and a multidisciplinary approach are critical for optimal outcomes. These international consensus recommendations summarize current best practices for LM management, offering practical, evidence-informed guidance to clinicians while acknowledging the potential of future research in refining these conclusions.
引用
- Forsea AM, Pampena R, Akay BN, et al. International Dermoscopy Society consensus recommendations for the management of lentigo maligna. J Eur Acad Dermatol Venereol. 2026. PMID: 41854120. doi:10.1111/jdv.70406
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。